NDA 18-644

2

 

Should you have any questions concerning this NDA, please contact Mr. Paul David, Consumer Safety Officer, at (301) 443-3504.

 

                                                                                                Sincerely yours,

 

 

                                                                                                Paul Leber, M.D.

                                                                                                Director

                                                                                Division of Neuropharmacological

                                                                                                Drug Products

                                                                                                Office of Drug Evaluation I

                                                                                                Center for Drug Evaluation and Research

Back a Page
Back to Wellbutrin SR. NDA Index Page
Back to Main Index